Thermoplastic Composite Matrix Patent Landscape 2026
Arkema France dominates a concentrated field where the top five filers account for 45% of the hundred largest filers’ combined output. Annual volume has eased back from its 2021 peak, placing the field in a post-peak phase that opens selective entry points for challengers.
Arkema France leads a heavily concentrated applicant field
Arkema France SA holds the clear leadership position with 94 patent records, more than four times the output of the second-ranked Cytec Industries at 20 patent records — a gap that signals entrenched proprietary positions in polyamide- and polyether-based matrix chemistries.
The top five filers collectively represent 45% of the hundred largest filers’ combined total, indicating a field where a small cluster of specialty chemical and polymer companies controls the dominant technical routes. The tier below the top five is fragmented, with most applicants holding fewer than ten patent records each.
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 1 | Arkema France SA | 94 | |
| 2 | Cytec Industries Inc | 20 | |
| 3 | ROHM & HAAS CO | 10 | |
| 4 | Solvay Specialty Polymers USA LLC | 9 | |
| 5 | BEIJING RES INST OF CHEM IND CHINA PETROLEUM & CHE… | 9 | |
| 6 | CHINA PETROLEUM & CHEMICAL CORP | 9 | |
| 7 | Anhui Xusheng New Concept Material Co Ltd | 8 | |
| 8 | SHPP Global Technologies BV | 8 | |
| 9 | FEDERAL MOGUL WIESBADEN GMBH & CO KG | 7 | |
| 10 | Rogers Corporation | 6 |
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 11 | DSM IP Assets BV | 6 | |
| 12 | Fraunhofer-Gesellschaft | 6 | |
| 13 | Victrex Manufacturing Ltd | 5 | |
| 14 | Hutchinson SA | 5 | |
| 15 | Syensqo Specialty Polymers USA LLC | 5 | |
| 16 | Harbin Institute of Technology | 4 | |
| 17 | Atofina SA | 4 | |
| 18 | University of Modena and Reggio Emilia | 4 | |
| 19 | SABIC Global Technologies BV | 4 | |
| 20 | The Dow Chemical Company | 4 |
Arkema’s concentration in condensation polymers (C08G 69), polymer compositions (C08L 77), and polymer processing (C08J 5) suggests the leadership position is built on vertically integrated chemistry — from matrix resin synthesis through composite processing — making displacement costly for challengers without equivalent resin portfolios.
Filing counts for 2024–2026 are likely under-represented due to standard 18-month publication lag; apparent recent softness should not be read as a structural retreat from the field. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Activity peaked in 2021; polymer composition chemistry dominates the technology mix
The filing trend and technology composition charts together reveal a field that surged to a 2021 high then moderated, anchored by a core of polymer-chemistry IPC classes with a long tail of application-specific branches.
Annual filing trend
Filings climbed from 19 in 2017 to a peak of 24 in 2021, then stepped down through 2022–2023. Values for 2024–2026 are likely undercounted due to publication lag and should not be treated as confirmed decline.
↗ Hover for values · click a bar to ask EurekaTechnology composition
C08L (polymer compositions) is the dominant class, followed closely by C08G (condensation polymers) and C08J/C08K (processing and additives). Shaping (B29C) and layered products (B32B) appear at lower frequency, indicating that matrix formulation patents outnumber fabrication-method patents by a wide margin. Sparse branches such as D06M (textile chemical treatment), H01B (cables and insulators), and B64C (aeroplanes) indicate niche application coverage rather than sustained programmes.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Thermoplastic composite material made of a semi-cr…
A composition for a thermoplastic composite material having a thermoplastic matrix made of a semi-crystalline polyamide having a specific composition that includes at least two amide units, A, 55-95 mol %, and B, 5-45 mol %. A corresponds to x.T, wherein x is a C<sub>9</sub>-C<sub>18 </sub>linear aliphatic diamine and B corresponds to x′.T, wherein x′ can… (excerpt from the patent abstract)
Open this patent in Eureka →| # | Patent | Citations |
|---|---|---|
| 1 | Thermoplastic composite material reinforced with s… | 125 |
| 2 | Hydroxy-phenoxyether polymer thermoplastic composi… | 97 |
| 3 | Thermoplastic composite material made of a semi-cr… | 92 |
| 4 | Fireproof Composition Based on Thermoplastic Matrix | 63 |
| 5 | Method for preparing a thermoplastic composite mat… | 56 |
| 6 | Photo-curing of thermoplastic coatings | 44 |
| 7 | Thermoplastic composite material reinforced with s… | 41 |
| 8 | Method for preparing a thermoplastic composite mat… | 33 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the field’s structure means for R&D investment decisions
Four structural observations — maturity, concentration, collaboration, and geography — frame where risk and opportunity are distributed across the thermoplastic composite matrix landscape.
Post-peak field with selective entry windows
The lifecycle stage is classified as Decline, with annual filings easing back from the 2021 peak. This does not preclude entry, but it does indicate that incremental formulation patents face a crowded prior-art base. Novel processing routes (B29C) or application-specific matrix systems in sparse classes represent lower-congestion paths.
Lifecycle: DeclineSingle dominant incumbent; fragmented second tier
Arkema France’s 94 patent records against Cytec’s 20 and Rohm & Haas’s 10 creates a sharp two-tier structure. The second tier is densely populated with specialty polymer houses, Chinese state-linked entities, and materials distributors, none of which approaches the leader’s scale. This gap suggests that unseating Arkema on core polyamide matrix chemistry would require either a breakthrough resin platform or an acquisition.
HHI: HighCytec–Solvay axis is the dominant co-filing partnership
The most active co-filing relationships observed are Cytec Industries with Solvay Specialty Polymers USA (9 joint filings) and Beijing Research Institute of Chemical Industry with China Petroleum & Chemical Corp (9 joint filings). A minor link exists between Cytec Industries and Syensqo Specialty Polymers USA (1 joint filing). These pairings reflect both a Western specialty-polymer axis and a Chinese state-enterprise axis, with no cross-bloc collaboration evident in the data.
Two ecosystemsChina is the leading jurisdiction by filing volume
China leads by patent-record count at 77, ahead of Europe (EPO) at 65 and the United States at 62. WIPO PCT filings at 35 confirm that key applicants are pursuing multi-jurisdictional protection. Japan, Canada, and France follow at lower volumes. The China lead, combined with Chinese state-enterprise co-filing activity, suggests growing domestic intent to build independence in high-performance thermoplastic matrix supply chains.
CN · EP · US top 3Go beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Cytec Industries Inc | Solvay Specialty Polymers USA LLC | 9 |
| Beijing Research Institute of Chemical Industry, Sinopec | China Petroleum & Chemical Corporation (Sinopec) | 9 |
| Cytec Industries Inc | Syensqo Specialty Polymers USA LLC | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Arkema France leads; Solvay Specialty Polymers is the key challenger to watch
Two applicants stand out for their scale and trajectory: Arkema France as the clear incumbent, and Solvay Specialty Polymers USA as the most active challenger by recent filing momentum among tracked entities.
Arkema France SA
Arkema France SA holds 94 patent records — by far the largest position in the field. Its technology focus centres on condensation polymers (C08G 69), polyamide-based compositions (C08L 77), and composite processing (C08J 5), consistent with its PEKK and polyamide matrix product lines. Momentum data show it as a new entrant in the recent filing window, suggesting a pivot or portfolio restructuring rather than a continuous linear build.
patent records: 94Solvay Specialty Polymers USA LLC
Solvay Specialty Polymers USA LLC holds 9 patent records and shares technical ground with Arkema in polyether compositions (C08L 71), condensation polymers (C08G 65), and additive systems (C08K 3). Its recent filing trend shows a 70% decline versus the prior period, indicating the portfolio may be in a consolidation or divestiture phase — consistent with broader Solvay group restructuring. The Cytec co-filing partnership (9 joint records) is a material part of its effective footprint.
patent records: 9| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Arkema France SA | 7 | ▲ new entrant |
| Solvay Specialty Polymers USA LLC | 3 | ▼ -70% |
Under-served branches adjacent to the dominant matrix chemistry core
Several IPC branches sit at low patent-record counts relative to the core C08 cluster. These are observations of relative sparsity; technical value and entry feasibility vary and are assessed below.
B32B · Layered products and laminates
With 23 patent records and a 2% share of classified records, layered-product claims are sparse relative to the volume of matrix-formulation patents. Thermoplastic composite laminates are a direct end-product of matrix technology and face growing demand in aerospace (B64C shows only 5 records) and automotive lightweighting. An applicant with a strong C08L or C08G position could extend into laminate architecture claims with comparatively low prior-art congestion, though freedom-to-operate against Arkema’s processing portfolio would need to be confirmed.
Search this in Eureka →D06M · Textile chemical treatment
D06M appears at 16 patent records and a 1% share, indicating that fibre-sizing and textile-interface chemistry — critical to fibre-matrix adhesion in reinforced composites — is under-covered in this corpus. Improved sizings for carbon or glass fibre in thermoplastic matrices remain a commercially relevant challenge for aerospace and sporting goods. This branch is adjacent to the dominant chemistry classes and could be addressed by applicants already active in C08K (additive use) or D01F (chemical fibre features, 13 records).
Search this in Eureka →How leading applicants differ by technology route
Route coverage across the main technology branches in the current evidence set.
| Player | C08L 77 · Polymer compositions | C08J 5 · Polymer processing & solutions | C08K 7 · Use of additives in polymers | C08G 69 · Condensation polymers | C08L 71 · Polymer compositions |
|---|---|---|---|---|---|
| Arkema France SA | Strong · 72 | Strong · 60 | Moderate · 26 | Strong · 78 | Absent |
| Cytec Industries Inc | Absent | Strong · 11 | Moderate · 5 | Absent | Strong · 14 |
| China Petroleum & Chemical Corporation (Sinopec) | Strong · 9 | Strong · 9 | Strong · 9 | Absent | Absent |
| Beijing Research Institute of Chemical Industry, Sinopec | Strong · 9 | Strong · 9 | Strong · 9 | Absent | Absent |
| SABIC Innovative Plastics IP BV | Absent | Strong · 7 | Strong · 8 | Absent | Strong · 7 |
| Anhui Xusheng New Concept Material Co Ltd | Strong · 8 | Moderate · 4 | Strong · 8 | Absent | Absent |
| Solvay Specialty Polymers USA LLC | Absent | Absent | Moderate · 5 | Emerging · 1 | Strong · 10 |
Frequently asked questions
Arkema France SA leads with 94 patent records, more than four times the next-ranked applicant, Cytec Industries Inc at 20 patent records.
The corpus covers 125 patent families in scope, with filing activity tracked from 2017 onward across more than 20 jurisdictions.
China leads at 77 patent records, followed by Europe (EPO) at 65 and the United States at 62. WIPO PCT filings at 35 confirm that the leading applicants are pursuing broad multi-jurisdictional protection.
The lifecycle is assessed as Decline, with annual filings easing back from a 2021 peak of 24. The recent-window growth figure is -51%, though 2024–2026 data are likely undercounted due to publication lag and should be interpreted cautiously.
C08L (polymer compositions), C08G (condensation polymers), C08J (polymer processing and solutions), and C08K (use of additives in polymers) collectively account for the largest shares of classified records, reflecting the chemistry-heavy nature of matrix development.
Two co-filing partnerships stand out: Cytec Industries with Solvay Specialty Polymers USA (9 joint filings) and Beijing Research Institute of Chemical Industry with China Petroleum & Chemical Corp (9 joint filings). These reflect a Western specialty-polymer axis and a Chinese state-enterprise axis operating largely independently of each other.
Ready to map your own thermoplastic composite matrix landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.